ASKER — Asker Healthcare AB Income Statement
0.000.00%
- SEK34.94bn
- SEK39.52bn
- SEK30.05bn
- 77
- 25
- 36
- 39
Annual income statement for Asker Healthcare AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 18,708 | 23,436 | 26,906 | 30,050 |
| Cost of Revenue | ||||
| Gross Profit | 2,613 | 3,782 | 4,519 | 5,878 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 17,512 | 22,020 | 25,748 | 28,118 |
| Operating Profit | 1,196 | 1,416 | 1,158 | 1,932 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 1,088 | 1,122 | 616 | 1,118 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 940 | 868 | 410 | 752 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | 934 | 860 | 406 | 722 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 934 | 860 | 406 | 720 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 27.7 | 23.3 | 10.8 | 6.74 |